Page last updated: 2024-11-05

carboxyl radical

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID6857677
CHEBI ID29325
MeSH IDM0121945

Synonyms (12)

Synonym
14485-07-5
[co2](.-)
carboxyl radical
co2(.-)
oco(.-)
CHEBI:29325
dioxidocarbonate(.1-)
oxidocarbonyl
carbon dioxide anion
carbon dioxide ion
carbon dioxide, ion(1-)
coo-

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The use of carbon nanotubes (CNTs) could improve medical diagnosis and treatment provided they show no adverse effects in the organism."( Combination of small size and carboxyl functionalisation causes cytotoxicity of short carbon nanotubes.
Fröhlich, E; Höfler, A; Leitinger, G; Meindl, C; Roblegg, E, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" Type I, parallel shift of the dose-response curve towards higher concentration by modification of COO- groups by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)."( Three types of chemical modification-effects induced by various chemical reagents on the glutamate receptors in molluscan neurons.
Kato, M; Kusano, K; Maruhashi, J; Oomura, Y, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
carbon oxide
organic radical anion
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (151)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (7.28)18.7374
1990's16 (10.60)18.2507
2000's62 (41.06)29.6817
2010's57 (37.75)24.3611
2020's5 (3.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.91%)5.53%
Reviews10 (6.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other144 (91.72%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]